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Abstract
The protozoan parasite Trypanosoma cruzi is able to target the thymus and induce alterations of the thymic
microenvironmental and lymphoid compartments. Acute infection results in severe atrophy of the organ and early release
of immature thymocytes into the periphery. To date, the pathophysiological effects of thymic changes promoted by
parasite-inducing premature release of thymocytes to the periphery has remained elusive. Herein, we show that
sphingosine-1-phosphate (S1P), a potent mediator of T cell chemotaxis, plays a role in the exit of immature double-negative
thymocytes in experimental Chagas disease. In thymuses from T. cruzi-infected mice we detected reduced transcription of
the S1P kinase 1 and 2 genes related to S1P biosynthesis, together with increased transcription of the SGPL1 sphingosine-1-
lyase gene, whose product inactivates S1P. These changes were associated with reduced intrathymic levels of S1P kinase
activity. Interestingly, double-negative thymocytes from infected animals expressed high levels of the S1P receptor during
infection, and migrated to lower levels of S1P. Moreover, during T. cruzi infection, this thymocyte subset expresses high
levels of IL-17 and TNF-a cytokines upon polyclonal stimulation. In vivo treatment with the S1P receptor antagonist FTY720
resulted in recovery the numbers of double-negative thymocytes in infected thymuses to physiological levels. Finally, we
showed increased numbers of double-negative T cells in the peripheral blood in severe cardiac forms of human Chagas
disease.
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Introduction
Chagas disease is an infection caused by the flagellate protozoan
Trypanosoma cruzi (T. cruzi) and represents a significant public
health burden in the Americas [1,2]. The disease develops from an
initial acute phase that progresses to an asymptomatic indeterminate
period, with virtually undetectable parasitemia, as a result of non-
sterile control of the parasite by strong humoral and cellular anti-T.
cruzi responses. Several years after the initial infection, approxi-
mately 20 to 30% of all infected individuals develop a chronic
inflammatory disease which primarily affects the heart [3–5].
The pathogenesis of Chagas disease is controversial and distinct
hypothesis have been considered, including autoimmune manifes-
tations and parasite-driven tissue damage [6–10]. In murine
models of acute Chagas disease, alterations have been observed in
lymphoid organs including the thymus, in which the parasite has
been detected [11]. Infected animals reveal a severe atrophy of the
organ, although not affecting the key intrathymic events respon-
sible for negative selection of thymocytes during thymopoiesis
[12].
Thymic atrophy is also seen in other infections and results from
the inflammatory syndrome mediated by TNF-a during the acute
phase of infection; this leads to activation of the hypothalamus-
pituitary-adrenal (HPA) axis with the consequent release of
corticosterone [13]. The rise in glucocorticoid levels during
infection is related to the extensive apoptosis of immature
CD4+CD8+ cells, which accounts for the atrophy of the thymus
[13–15], together with the premature release of recent thymic
emigrant cells, including CD4+CD8+ thymocytes [16–18]. More-
over, we found that increased percentages of circulating
CD4+CD8+ T cells exhibiting an activated HLA-DR+ phenotype
are associated with severe cardiac forms of human chronic Chagas
disease [12]. However, it remains unknown if there is an
involvement of CD42CD82 T lymphocytes in the pathogenesis
of this infection. Extrathymic CD42CD82TCR+ cells that lack the
expression of both CD4 and CD8 T cell co-receptors, are found in
several immune disorders, representing key players in autoimmu-
nity and inflammation [19–21].
The premature release of immature thymocytes in Chagas
disease likely results from T. cruzi-induced alterations of the
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thymic microenvironment represented by an increased deposition
of migration-related cell molecules, such the extracellular matrix
(ECM) proteins, fibronectin and laminin, as well as the CXCL12
and CCL21 chemokines in the thymus [22]. Additionally, the
infection induces an increase in the expression of the fibronectin/
laminin integrin receptors VLA-4 and VLA-6 in thymocytes,
resulting in an enhanced fibronectin/laminin-driven migration of
thymocytes during the T cell maturation [23]. The cell-matrix-
driven migration is settled by the interaction of thymocytes with
thymic epithelial cells, as well as other cell types of the thymic
microenvironment. This process is important for thymocyte
migration within thymic compartments, along which the thymo-
cytes become sensitive to regulation of exit by the chemo-
attractant receptor CCR7 and the receptor for sphingosine-1-
phosphate (S1PR1) [24,25].
Sphingosine-1-phosphate, a breakdown product of sphingolipid
metabolism, is present in all mammalian cells and serves as a
second messenger in signal transduction pathways. Reversible
systemic and local synthesis of S1P is mediated by sphingosine
kinases (SPHK1/2) and S1P phosphatases (SGPP1/2), whereas
irreversible degradation of S1P is carried out by a single enzyme,
S1P lyase (SGPL) [26]. S1P is released into the extracellular milieu
by a variety of cell types, making it one of the most abundant
biologically active lysophospholipids in circulation [27–29].
Autocrine and paracrine interactions between S1P and a family
of five different G protein-coupled receptors (S1PR1-5) have been
implicated in a wide range of physiological activities, including
immunity [30,31]. It has been shown that the S1P receptor surface
expression on lymphocytes is critical for their egress from thymus
and lymph nodes. Increased surface expression of S1PR1 renders
T cells responsive to S1P chemotactic signals and promotes their
emigration from lymphoid tissues, whereas S1PR1 is downregu-
lated during peripheral lymphocyte activation, and this fate is
associated with cell retention in the lymphoid organs [24,25,32].
We investigated herein the role of the S1P pathway in
Trypanosoma cruzi-induced thymus atrophy. Our findings indicate
that the intrathymic levels of S1P kinase activity decrease in T.
cruzi acutely infected mouse thymus. This is associated with
upregulation of S1PR1 receptor expression and increased
chemotactic responsiveness of CD42CD82 thymocytes to S1P.
When acutely-infected animals were systemically treated with
FTY720, a potent antagonist of the S1P receptor, the reduction of
the thymic cellularity seen in T. cruzi infection was significantly
abrogated and the intrathymic contents of CD42CD82 thymocyte
population were recovered. Our data indicate that CD42CD82
thymocytes exhibit a pro-inflammatory like activation pattern,
based on IL-17 and TNF-a expression gene profiles, and that the
S1P signaling pathway exerts a critical role on the premature
release of these cells during T cruzi-induced thymic atrophy.
Finally, increased numbers of circulating CD42CD82 T cells were
also found in chronic chagasic patients bearing severe cardiopathy.
Materials and Methods
Ethics statement
The study was approved by the Research Ethics Committee of
National University of Rosario, (protocol UNR-CD Nu2854/2008
and CS Nu131/2010) and Fiocruz (protocol CEUA-LW8/10).
Protocols for animal and human studies were approved by the
Institutional Ethical Committees in accordance with international
guidelines. All animal experimentation was performed in accor-
dance with the terms of the Brazilian and Argentine guidelines for
the animal welfare regulations. All subjects in the study were adult
and provided a written informed consent.
Study population
Healthy volunteers and chronic chagasic patients were recruited
from Chagas Unit, Hospital Provincial del Centenario de Rosario,
UNR, Argentina. Subjects using any medication thought to affect
immune functions were excluded from the study. The diagnosis of
T. cruzi infection was based on two standard serological tests
including indirect immunofluorescence and haemaglutination
assay. The ages of all chronic infected patients and healthy
volunteers that participated in the study reanged from 30 to 70
years. Seropositive cases included eleven cardiac chronically-
infected patients presenting dilated cardiomyopathy diagnosed
based on a detailed clinical examination, as well as electrocardi-
ography (ECG) and chest X-ray. Additionally, we included twelve
chagasic patients without any cardiac alterations detected, being
diagnosed as in the indeterminate or asymptomatic form of the
disease. Ten sex and age matched-controls were also included.
Animals, infection and drug treatment
Male BALB/c mice, aged 4–8 weeks, were obtained from the
animal facilities of Oswaldo Cruz Foundation and Federal
University of Rio de Janeiro or from the Faculty of Medical
Sciences of National University of Rosario. Acute T. cruzi
infection was performed by inoculating the animals intraperito-
neally with 102 blood-derived trypomastigote forms of the
Tulahuen strain, after isolation from BALB/c mice. At different
days post-infection, animals were killed and the organs to be
studied were removed. Blood parasites were counted using
Neubauer’s chambers. For blocking the S1P-mediated egress of
thymocytes, infected mice were treated with FTY720 (5.0 mg/kg),
the functional antagonist for S1PR1 [33], every two days through
was administrated in vivo through intraperitoneal injections from
6 dpi to 16 dpi. At day 17 dpi, animals were killed for further
analysis.
Lipid phosphorylation assay, extraction and analysis
To ascertain the activity of SPK activity we performed a lipid
phosphorylation assay as previously described [34]. Briefly, we
Author Summary
The formation of mature lineage-committed T cells
requires the specialized environment of the thymus, a
central organ of the immune system supporting the
development of self-tolerant T cells. Key events of
intrathymic T-cell development include lineage commit-
ment, selection events and thymic emigration. This organ
undergoes physiological involution during aging. Howev-
er, acute thymic atrophy can occur in the presence
autoimmune diseases, malignant tumors and infections
caused by intracellular pathogens. The present study
shows that the protozoan parasite Trypanosoma cruzi
changes the thymic microenvironmental and lymphoid
compartments, resulting in premature release of very
immature CD42CD82 double-negative thymocytes,
TCRneg/low, which bear a pro-inflammatory activation
profile. Strikingly, we also found elevated levels of these
undifferentiated T lymphocytes in the peripheral blood of
patients in severe cardiac forms of chronic Chagas disease.
Importantly, we provided evidence that migration of
CD42CD82 T cells from infected mouse thymus is due to
sphingosine-1-phosphate receptor-1-dependent chemo-
taxis. These findings point to an important role for
bioactive signaling sphingolipids in the thymic escape of
immature thymocytes to the periphery in Chagas disease.
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used 0.2 mg protein/ml from each sample and the assay medium
(1 ml) contained 30 mM MES-Tris (pH 7.0), 1 mM [c-32P]ATP
(specific activity 2.26108 cpm/mmol), 1.1 mM MgCl2, 10 mM
NaN3, 1 mM ouabain, and 0.5 mM EGTA. The reaction was
started by the addition of [c-32P]ATP to the tubes. One ml
aliquots of the different samples at the different experimental
conditions were used for total lipid extraction, which was
performed as previously described [34]. Briefly, 5.0 ml of the
solvent moisture (CHCl3:MeOH:HCl – 20:10:0.075 v/v) was
added to the samples at conic glass tubes and vigorous mixed using
a Pasteur pipete. After 10 min on ice, it was added 1.0 ml 0.6 M
HCl followed by intense mix with the Pasteur pipette. The tubes
were centrifuged at 6006g for 10 min, and the lower phase
(containing the lipids) was carefully removed for another glass tube
and washed twice with 1.0 ml of CHCl3: MeOH: 0.6 M HCl
(3:48:47 v/v) followed by centrifugation at 6006g for 10 min. The
upper phase was removed and the lower phase was dried under
N2. Total lipid content was determined gravimetrically. Lipids
were separated and first identified by TLC, using a solvent system
consisting of chloroform:acetone:methanol:acetic acid:water
(120:45:39:36:24, v/v). Then, the [c-32P]ATP containing phos-
phorylated lipids were detected in the autoradiograms of the TLC
plates. To quantify the amount of S1P formed, the corresponding
spot was scrapped and placed in vials for liquid scintillation
counting (Tri-Carb 2100; Packard).
Immunohistochemistry
Immunofluorescence analysis was performed to assess the
intrathymic expression of S1PR1. For this purpose, thymuses
were removed from 14 dpi and uninfected mice, embedded in
Tissue-Tek (Miles, Elkhart, IN) and frozen in liquid nitrogen. Five
4 mm-thick cryostat sections were settled on poly-L-lysine (Sigma,
St. Louis, MO) covered glass slides, acetone fixed and blocked with
1% PBS-BSA. Samples were submitted to specific rabbit anti-
mouse EDG1 antibody (Abcam, Cambridge, UK), 1:50 for 2 hour
at room temperature, washed and submitted to appropriate
secondary antibody, 1:500 goat anti-rabbit Alexa 488 (Molecular
Probes, Eugene, USA) respectively. Negative control was obtained
by omitting primary antibodies. Samples were analyzed by
confocal microscopy using a LSM 510 Zeiss device (Germany)
and the images obtained were subsequently analyzed using the
Image J software (NIH, Bethesda, MD).
Isolation of human peripheral blood cells (PBMC),
antibodies and flow cytometry
Heparinized whole blood was collected and diluted 1/2 with
PBS before separated by density centrifugation on Ficoll-Hypaque
(Sigma) for 30 min at 2000 rpm. For human T cell phenotyping,
individual samples contained 106 living cells were pre-treated with
human AB serum for 15 min and stained at 4uC for 30 min
simultaneously with three colors using the following antibodies:
APC-labeled anti-CD3, APCCy7-labeled anti-CD4, PECy7-la-
beled anti-CD8 antibodies (BD/PharMingen, CA). For FACS
analysis, PBMC cells were then fixed and analyzed and CD3+ T
lymphocytes were gated based on forward and side scatter
parameters followed by CD3+ expression to avoid larger
leukocytes such as macrophages and granulocytes.
For murine T cell phenotyping experiments, thymuses, subcu-
taneous lymph nodes and spleens from 6–10 week-old mice were
dissected and mechanically disaggregated. Single cell suspensions
were obtained using a 40 mm cell strainer. Red blood cells were
removed by NH4Cl lysis. Cells were diluted in 1% BSA-PBS and
incubated with anti-FccR antibody (BD Biosciences, California,
USA) to block the binding of conjugated antibodies to FccR.
Individual samples stained at 4uC for 30 min simultaneously with
different combination of the following antibodies for FACS
analysis: PerCP-labeled anti-CD3, PE-cy7-labeled anti-CD4,
APC-labeled anti-CD8, FITC-labeled anti-CD11b, FITC-labeled
anti-CD161 (NK T cell specific), PE-labeled anti-CD11c, PE-
labeled anti-CD45, PE-labeled anti-TCRcd. For the character-
ization of DN T cells TCR+, CD4 and CD8 staining was
combined with the PE-labeled anti-TCR Vbeta reagent. All the
antibodies were obtained from BD Biosciences. After staining, cells
were then fixed and analyzed by FACS Canto II flow cytometer
(Beckton Dickinson, CA). Analyses were done by duplicate,
recording 25,000–50,000 events for each sample, then using the
DIVA software (Becton Dickinson). Lymphocytes were gated
based on forward and side scatter parameters, so as to avoid larger
leukocytes such as macrophages and granulocytes.
Isolation of thymic CD42CD82 cells and quantification of
mouse mRNA transcripts
CD42CD82 T lymphocytes were isolated from three pooled
thymuses obtained from infected (14 dpi) and uninfected (control)
mice by FACS cell sorting using PE-cy7-labeled anti-CD4, APC-
labeled anti-CD8. For quantification of mRNA transcripts, RNA
was extracted from CD42CD82 enriched cells (5.105 per group)
using a commercially available kit (RNeasy Mini Kit, Qiagen,
Venlo, NL). For total thymus analysis, RNA was isolated using
guanidine thiocyanate kit (Invitrogen, California, USA) per the
manufacturer’s instructions. First strand cDNA synthesis was
prepared with 0.5 mg total RNA, random hexamer primer, and
SuperscriptIII reverse transcriptase (Invitrogen, California, USA).
For qPCR we used approximately 60 ng of cDNA for each sample
and SYBR Green Master Mix 2 (Applied Biosystems, California,
USA). cDNA was amplified using specific murine primer
sequences described in Table 1. All reactions were run on an
ABI Prism 7700 sequence detection system (Applied Biosystems,
Foster City, CA). After 40 cycles of amplification, expression of
GAPDH (Gapdh), S1PK1 (Sphk1), S1PK2 (Sphk2), S1PP1
(Sgpp1), S1PP2 (Sgpp2), S1PL (Sgpl1), S1PR1 (S1pr1), S1PR3
(S1pr3), IL17 (Il17a) and TNFa (Tnf) was assessed by comparing
the expression of each to the normalizer GAPDH using the Ct
method as previously described (22DCt) [35], subsequent to the
following primer efficiency analysis. Each experiment was run in
triplicate with different cDNA preps from the same mice.
GenBank accession number for each of these genes can be seen
in Table 1.
Evaluation of recent thymic emigrants
Intrathymic injection of fluoresceinisothiocyanate (FITC) for
direct evaluation of recent thymic emigrants (RTEs) in the mouse
model were performed as originally described by Scollay et al [36]
with minor modifications. Briefly, animals were anesthetized
(ketamine at 100 mg/kg and xylaxine at 2 mg/kg) and then the
chest was opened to expose the thymus. A Hamilton syringe was
used to inject 10 mL/lobe of 1 mg/ml FITC solution, prepared
from a saturated stock diluted in phosphate-buffered saline.
Control group was injected with saline alone. After intrathymic
injection, the skin incision was closed and mice were allowed to
recover under a heat source. To evaluate RTEs, animals were
sacrificed 24 hours post-injection, and thymus, spleen as well as
axillary and inguinal subcutaneous lymph nodes were removed.
Lymphoid cells from each organ were suspended in PBS solution
containing 5% fetal calf serum; being then labeled with PE-labeled
anti-CD3, APC or PECy7-labeled anti-CD4, PECy7or APCCy7-
labeled anti-CD8 antibodies (BD/PharMingen) for monitoring
FITC+ T cells by flow cytometry. To determined DN stages we
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also stained cells with PECy5-labeled anti-CD44 and APC-labeled
anti-CD25 antibodies (BD/PharMingen). Only animals with more
than 50% of FITC+ thymocytes were used for subsequent analysis.
Peripheral cells were considered RTEs when FITC+ cells could be
distinguished from FITC2 cells, comparing with animals that only
received intrathymic injection of saline. Data were evaluated as
absolute numbers or percentages of FITC+ cells present in the
perypheral lymphoid organs.
Chemotaxis assay
The response of thymocytes towards sphingosine-1-phosphate
was studied using Transwell inserts with a 5 mm pore size (Corning,
Cambridge, MA). Briefly, unspecific binding sites of the inserts were
blocked with fatty-acid free PBS/BSA 0.1% (Sigma –Aldrich, St.
Louis, MO) during 15 min at 37uC. Unbound BSA was then
removed before adding thymocytes. The migratory response of
thymocytes obtained from 14 dpi infected mice was analyzed under
S1P concentrations of 0.01, 0.1, 1, 10 and 100 nM and BSA was
used as control. Further, CD42CD82 and CD4+CD8+ T cells were
isolated at 14 days post-infection or from uninfected counterparts by
cell sorting and their migration was assessed under a fixe 0.01 nM
concentration of S1P. Cell suspensions (100 ml at 56105/ml) in
RPMI 1640 medium plus 0.4 mg/ml fatty acid-free BSA (Sigma)
were added to the upper chambers. Each insert was placed in a well
containing 600 ml of a solution of sphingosine-1-phosphate (Avanti),
0.1 nM, prepared in medium containing fatty acid-free BSA. Wells
containing medium in the presence of fatty acid-free BSA without
sphingosine-1-phosphate were used as controls. After 3 h at 37uC,
cells in the wells were harvested, counted, and analyzed by flow
cytometry. The percentage of each thymocyte subset was assessed
from absolute cell counting to assess the total numbers of each
CD42CD82 and CD4+CD8+ subset. The specificity of
CD42CD82 T cell migration towards S1P, was confirmed by the
previous incubation of these cells with FTY720, 102 nM, during
30 min at 37uC. Both S1P and FTY720 working concentrations
were selected after the obtainment of a dose-response curve.
In vitro activation of CD42CD82 T cells
To access the cytokine-producing in vitro, CD42CD82 enriched
lymphocyte suspensions (56105 cells), obtained from thymuses of
both uninfected and 14 dpi mice, were cultured in lymphocyte
culture medium supplemented with 10 ng/mL phorbol 12-myris-
tate 13-acetate (PMA) 500 ng/mL ionomycin and 5 mg/mL of
brefeldin A (all from Sigma-Aldrich) for 3 hours, at 37uC. The cells
were then recovered and ressuspended in a lysis buffer, prior to
RNA isolation (RNeasy Mini Kit, Qiagen, Venlo, NL).
Statistical analysis
Statistical analyses were performed with GraphPad Prism 4
software, using one-way ANOVA test. In humans, we used non-
parametric tests. Non-parametric Kruskall-Wallis test (k groups .
2) followed by the U Mann-Whitney test (k groups = 2). Results
were expressed as mean 6 standard error (S.E.). Differences
between control versus treated group were considered statistically
significant when P,0.05.
Results
Trypanosoma cruzi infection promotes abnormal release
of immature thymocytes
In the mouse model of acute T. cruzi infection, BALB/c mice
were injected intraperitoneally with 102 Tulahue´n trypomastigote
Table 1. General features of genes whose expression was evaluated by quantitative RT-PCR analysis.*
Symbol GenBank Description Description
Gadph NM_008084.2 Glyceraldehyde-3-phosphate dehydrogenase CCGCCTGGAGAAACCTGCCAAGTAT (FW)
TTGCTCAGTGTCCTTGCTGGGGT (RV)
Sphk1 NM_001172475.1 Shingosine kinase 1 GGAGGAGGCAGAGATAACCTT (FW)
GACCCAACTCCCTGCACACA (RV)
Sphk2 NM_001172561.1 Sphingosine kinase 2 GCCCGAGATGGTCTAGTCT (FW)
GTGGGTAGGTGTAGATGCAGA (RV)
Sgpp1 NM_030750.3 Sphingosine-1-phosphate phosphatase 1 GGGTGCTGGTCATGTACCTG (FW)
CCCGTAGATAAGAGGATAGTGCC (RV)
Sgpp2 NM_001004173.2 Sphingosine-1-phosphate phosphatase 2 GTTCTCTACGCTGGTGTGTCT (FW)
GCAGGGTAGGTGAGAGCAAT (RV)
Sgpl1 NM_009163.3 Sphingosine phosphate lyase 1 CCTGTGTACTCTGCTGATAGTCT (FW)
CTGTTGTTCGATVVTACGTCCA (RV)
S1pr1 NM_007901.5 Sphingosine-1-phosphate receptor 1 GTGGGCTGCAAGGTGAAGACCTGT (FW)
TTTCTGGGGGTGGGAGGAATTGTC (RV)
S1pr3 NM_010101.4 Sphingosine-1-phosphate receptor 2 GCCCATCCTCTTCAAGGCTCAGT (FW)
GTGGGGCAGGTCTTCCTTGACCTT (RV)
Il17a NM_010552.3 Interleukin 17a TCATCCCTCAAAGCTCAGCG (FW)
TTCATTGCGGTGGAGAGTCC (RV)
Tnf NM_013693.2 Tumor necrosis factor TGTCTACTGAACTTCGGGGT (FW)
TCCACTTGGTGGTTTGCTAC (RV)
*Symbols, GenBank accession numbers and descriptions of the genes mentioned in the text, as well as the corresponding nucleotide sequences of primers used for the
analysis of transcripts.
doi:10.1371/journal.pntd.0003203.t001
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parasites. This induced severe thymic atrophy that is evident 10
days post-infection, is mainly due to the CD4+CD8+ double
positive loss (Figure S1). As expected, we also found a marked
increase in the number of total splenic and subcutaneous lymph
node T cells in such T. cruzi-infected mice (Fig. 1A). Conversely,
in the thymus itself there was a significant reduction in the total
thymocyte numbers from day 7 post-infection to the late stage of
acute infection (Fig. 1A and Figure S2).
To confirm that the atrophy in T. cruzi-infected mice was also
related to the premature release of thymocytes we labeled thymocytes
by intrathymic injection of fluorescein isothiocyanate (FITC) (Figure
S2). On the day after FITC injection, the numbers of peripheral
FITC+ cells expressing the CD3 T cell marker were determined in
the lymphoid organs. We found evidence of an abnormal escape of
both immature CD42CD82CD3+FITC+ and CD4+CD8+CD3+
FITC+ to the periphery during infection, as indicated by the numbers
of RTEs detected in the spleen and lymph nodes at 10 dpi (Fig. 1B).
There was also as increase in the absolute numbers of conventional
CD4+ and CD8+ single-positive T cells in the peripheral lymphoid
tissues analyzed (Fig. 1B). Strikingly, higher proportion of FITC+
bearing DN cells CD42CD82CD442CD25+ (DN3) and CD42
CD82CD442CD252 (DN4) cells were observed in the spleen of
infected animals (Figure S3).
Modulation of the thymic sphingosine pathway in T. cruzi
acute infection
We next investigated whether the early release of thymocytes in T.
cruzi acute infection could be favored by the modulation of the
sphingosine-1-phosphate (S1P) pathway, which is critical to license
mature thymocytes for trafficking competence and emigration from
the thymus. A dynamic balance between S1P and its precursors,
ceramide and sphingosine, is an important factor that determines
thymocyte fate [31]. Sphingosine-1-phosphate is generated by the
phosphorylation of sphingosine, catalyzed by two sphingosine kinases,
SPHK1 and SPHK2. It is inactivated through reversible dephos-
phorylation by two phosphatases, SGPP1 and SGPP2, and through
definitive degradation by the lyase, SGPL1. To address this issue, gene
expression profiles of the enzymes involved in the S1P pathway, were
compared between normal versus T cruzi-infected thymus during
acute phase at days 7, 10 and 14 post-infection by using quantitative
real-time PCR (qPCR). As shown in Figure 2A, SPHK1/2 expression
was significantly reduced in the thymuses from infected animals as
compared to non-infected controls. In contrast, there was an up-
regulation of the SGPL1 at 10 dpi, whereas the expression of SGPP1/
2 remained unaltered in T cruzi-infected thymuses compared to the
normal expression seen in the control-uninfected group. These
findings suggest that S1P catabolism may be activated upon T cruzi-
infection. In fact, TLC analysis of lipids present in both infected and
normal thymuses indicated that in acutely T cruzi-infected thymus,
there is a significant decrease in the S1P kinase activity when
compared to the physiological condition (Fig. 2B).
Despite the differences in the thymus, serum S1P levels were
comparable in both infected and normal mice (Fig. 2B). These
results indicate an increased gradient in the S1P levels from
thymus to the blood during the T. cruzi-induced thymic atrophy
that may favor the exit of thymocytes in the infection.
The S1PR1 and S1PR3 receptors are up-regulated in the
double-negative thymocytes from T cruzi-infected
thymuses and following chemotaxis to lower doses of
S1P
We further analyzed whether the modulation of the S1P
pathway also comprised the thymic expression S1PR1 and S1PR3,
the major S1P receptors involved in S1P-induced T cell migration
[37,38]. As demonstrated in Figure 3A and B, S1PR1 was higher
in the cortical thymic compartments of infected animals (14 dpi)
than in the corresponding regions of non-infected control mice.
Yet, we did not detect any alteration in the S1PR3 protein
expression levels (data not shown).
We next assessed the expression of the S1P receptor in
developing thymocytes. To this end, both CD42CD82 and
CD4+CD8+ cells were purified by FACS (Fig. 3C) and S1PR1 and
S1PR3 gene expression levels were determined by real-time RT–
PCR analysis (Fig. 3D). We found a substantial up-regulation of
the S1PR3 mRNA in immature CD42CD82 as well as
CD4+CD8+ thymocytes from the infected mice, as compared
with their uninfected counterparts (Fig. 3D). Furthermore, there
was an increase in S1PR1 expression in CD42CD82, but not in
CD4+CD8+ T cells (Fig. 3D), pointing to different mechanisms
driving the exit of these two immature thymocyte subsets. These
findings suggest that an S1P-mediated pathway may regulate the
premature exit of immature thymocyte cells from the thymus,
particularly the CD42CD82 thymocytes (Fig. 3D).
Next we assessed the sensitivity of thymocytes to S1P-mediated
chemotaxis during T. cruzi-induced thymus atrophy. Using the ex-
vivo transwell migration assay, we first analyzed the chemotactic
response of total thymocytes at day 14 after T. cruzi infection from
0.01 to 100 nM S1P. The results show significantly higher
sensitivity of the migratory response of thymocytes from the
infected animals, exhibiting a double-peak at 0.1 and 10 nM doses
of S1P (Fig. 4A).
Considering the increased expression of the S1P receptors in
immature thymocytes upon T. cruzi infection, we tested the
importance of S1P-mediated chemotaxis in these cells. Phenotype
characterization of total migrating cells obtained by FACS analysis
showed the migratory response of CD42CD82 T cells peaks at
lower concentration of the S1P stimuli (0.1 nM) than in the
CD4+CD8+ T cells (10 nM), as represented respectively in
Figures 4B and C. The higher sensitivity of the CD42CD82 cells
to S1P-mediated chemotaxis is likely due to the augmented
expression of both receptor types S1PR1 and S1PR3 in
comparison to CD4+CD8+ cells, which increased only the
S1PR3 receptor during T. cruzi infection (Fig. 3D).
The lower dose of S1P may have an effect during the T. cruzi
infection as we show a steeper decrease in the concentration of this
chemotatic agonist in the thymus following infection (Fig. 2B). In
this regard, our data suggest that the disturbance of the
physiological thymic levels of S1P have a target effect on the
CD42CD82 thymocytes during T. cruzi infection. To address this
issue, CD42CD82 and CD4+CD8+ thymocytes were purified by
cell sorting from both normal and chagasic thymuses at day 14
post-infection and the role of S1P receptors in mediating cell
chemotaxis to S1P was compared on a per cell basis by using an in
vitro transwell migration assay. This effectis not seen in the normal
thymus, since we found that at the lower S1P agonist concentra-
tion (0.1 nM) neither CD4+CD8+ nor CD42CD82 cells isolated
by cell sorting from non-infected control thymuses responded to
the S1P stimuli as the basal migration values obtained when BSA
was applied were similar to those seen in the presence of S1P
(Fig. 4D and E).
We then aimed to characterize the CD42CD82 thymocyte
subset from T. cruzi-infected animals responding to S1P. By using
multicolor cytofluorometric analysis after immunostaining with
major cell surface markers that are known to characterize
thymocyte subsets, our results indicated that the majority (.
90%) of the migrating CD42CD82 thymocytes purified from T.
cruzi-infected animals responding to the S1P-driven chemotaxis
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Figure 1. Trypanosoma cruzi acute infection promotes the premature release of CD42CD82 thymocyte cells to the periphery. BALB/c
mice were intrathymically injected with FITC solution or PBS only as a control. After 24 h, lymphoid tissues were harvested and cells stained with anti-
CD4 and anti-CD8, for the identification of the specific subsets of recent thymic emigrants (RTEs) by flow cytometry. (A) Graphs represent the
absolute numbers of total T cells in the thymus, spleen and subcutaneous lymph nodes (SCLN) during T. cruzi acute infection and uninfected mice.
(B) Histograms represent the total numbers of RTEs (FITC+ cells) bearing the CD4+, CD8+, CD4+CD8+ and CD42CD82 T cell phenotype, obtained from
the spleen (right panel) and SCLN (left panel), as indicated. Data are shown as means6 SE (n = 6 mice per group). Differences between uninfected
and infected mice are significant * (p,0.05), ** (p,0.01), *** (p,0.001).
doi:10.1371/journal.pntd.0003203.g001
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were identified as potential CD42CD82 T cells (Figs. 4F and 4G).
Actually, roughly 70% of migrating CD42CD82 thymocytes
exhibited membrane expression of the TCR Vb protein. We
further showed that the migration of these CD42CD82TCRVb+
T cells towards S1P agonist was blocked using the FTY720 specific
inhibitor [33] of the cognate S1P receptors (Figs. 4G and 4H).
S1P is critical for determining CD42CD82 thymocyte
egress during T. cruzi infection
The data showed above suggested that S1P-triggered chemo-
taxis contribute to CD42CD82 T cell egress from the thymus
during the acute phase of T cruzi infection. We then determined
whether the disturbance of the thymic S1P pathway seen in T.
cruzi infection could play any role in the export of CD42CD82
thymocytes during atrophy of the thymus. To test this hypothesis
we injected mice with the FTY720 compound, the S1P receptor
inhibitor [33]. As we have previously demonstrated, T. cruzi
infection leads to atrophy of the thymus, which is evident after day
10 post-infection [12,39], with a significant decrease in cell
numbers when compared with uninfected mice (Fig. 5A). In
contrast, T. cruzi infected mice treated with FTY720 in doses
administered intraperitoneally every 2 days from day 6 up top day
16 post-infection, partially reverted the thymic cellularity (Fig. 5A).
This phenomenon occurred without any alterations in the
frequency of CD4+CD8+ compartment (Fig. 5B and C), the major
target cells in the T. cruzi induced thymic atrophy. By contrast, we
Figure 2. Down-modulation of intrathymic levels of S1P kinase activity in T. cruzi acutely-infected mice is associated with catabolic
gene expression of the S1P pathway. Thymuses were collected from normal or T. cruzi-infected BALB/c on days 7, 10 and 14 post-infection (dpi)
for measurements of the expression of S1P metabolic genes by real-time PCR and the levels of S1P levels by TLC. (A) mRNA levels of murine S1P
kinases (SPHK1/2), S1P phosphatases (SGPP1/2) and the S1P lyase (SGPL1) from normal and T. cruzi-infected thymuses. Quantitative PCR results were
normalized to values obtained from uninfected thymuses. Gene expression was assessed by comparing the expression of each to the normalizer
GAPDH using the Ct method and is represented as mean 6 SE of three independent experiments (n = 3 mice per group). (B) S1P kinase activity in
thymuses and sera from normal or infected mice were measured by TLC, as described in Materials and Methods. C17-S1P was used as the internal
standard. Graphs show the average values from two independent experiments (n = 6 mice per group), with error bars representing the standard error.
Differences between uninfected and infected mice are significant * (p,0.05), ** (p,0.01), *** (p,0.001).
doi:10.1371/journal.pntd.0003203.g002
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Figure 3. T. cruzi acute infection increases expression of S1P receptors in CD42CD82 thymocytes and thymic cortical compartment.
(A) Thymuses were stained with anti-S1PR1 monoclonal antibody and analyzed by immunofluorescence. Representative confocal microscopy fields
of thymuses stained with anti-S1PR1 monoclonal antibody and goat-anti rabbit alexa-488 secondary antibody are shown in (upper left) normal
thymus and (upper right) atrophic thymus at day 14 post-infection. The respective staining controls without the primary antibodies are shown in
(lower left) and (lower right). Scale bar = 100 mm. (B) Graphs correspond to relative quantitation analysis of S1PR1 deposition from 5 microscopic
fields of thymuses from control (n = 3) or infected animals (n = 3). It is clear the increase in S1PR1 within the cortex of thymic lobules from infected
animals. (C) CD42CD82 and CD4+CD8+ T cells from normal and acutely-infected mice (14 dpi) were purified from thymus, by cell sorting using flow
cytometry to assess the transcriptional levels of S1P receptors. Plots show the high purity of isolated CD42CD82 and CD4+CD8+ T cells (.95%). (D)
Total mRNA from purified CD42CD82 and CD4+CD8+ T cells were processed for RT-PCR. The results represent the amount of transcripts, depicted in
relation to the housekeeping gene GAPDH as 22DCt. There is a significant increase in the contents of both S1PR1and S1PR3 transcripts when
comparing control versus infected CD42CD82 T cells, whereas only S1PR3 transcripts increased in the CD4+CD8+ T subset relative to the controls.
Data are means 6 SE of two independent experiments using six mice per group. Differences between control and infected mice are significant * (p,
0.05), ** (p,0.01) and *** (p,0.001).
doi:10.1371/journal.pntd.0003203.g003
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observed a significant increase in the amounts of CD42CD82 cells
as well as CD4+ and CD8+ single-positive thymocytes (Fig. 5C).
In parallel to the thymic atrophy and reduction of immature
thymocytes, during T. cruzi infection there is an increase in the
numbers of CD42CD82Vb+ T cells in peripheral lymphoid
organs (Fig. 5D). In contrast, T. cruzi infected mice treated with
FTY720, significantly reverted the increase in the amounts of
CD42CD82 T cells seen in peripheral lymphoid organs of
infected mice (Fig. 5D), indicating cell sequestration in the thymus,
secondary to the blockage of the S1P pathway (Fig. 5C). The
mean fluorescence intensity of the TCR Vb was clearly low in
CD42CD82 T cells, when compared to CD8+ mature cells
expressing high TCR membrane levels (Fig. 5E).
Peripheral CD42CD82 T cells in Trypanosoma cruzi
infection express mRNA levels for TNF-a and IL-17
Since our findings indicated that CD42CD82 thymocytes are
abnormally released from the thymus in T. cruzi infection, we then
attempted to demonstrate whether these cells could have an
activation profile, as ascertained by the regulation of cytokine
genes upon stimulation. To address this question, thymic
CD42CD82 cells were purified by FACS cell sorting from normal
or infected animals 14 days after infection (Fig. 6A), and total
RNA was isolated after polyclonal activation with phorbol
myristate acetate (PMA) and ionomycin. Quantitative PCR
analysis revealed a significant gene expression induction of the
cytokines IL-17 and TNFa in CD42CD82 T cells from T. cruzi
infected mice, as compared to double-negative thymocytes purified
from uninfected control mice (Fig. 6B).
Abnormal high contents of CD42CD82 T cells in
peripheral blood from chronic chagasic patients
In the light of the evidence described above, in the last set of
experiments we searched for the presence of peripheral
CD42CD82 T cells in human Chagas disease, particularly in
patients bearing severe cardiomyopathy. For this purpose, we
examined the frequencies of peripheral blood CD42CD82 T cells
in cross-sectional studies of chronic chagasic patients at the
indeterminate or cardiac clinical forms of Chagas disease,
compared to age/sex-matched healthy individuals.
We found a significant increase in the relative numbers
CD42CD82 T cells in cardiac chagasic patients, as compared
Figure 4. S1P promotes migration of immature thymocytes from T. cruzi-infected mice. Migratory responses of thymocytes isolated from
infected and normal mice were assessed in transwell chambers as described in Materials and Methods. S1P was added to the lower chamber at the
indicated concentrations. (A) Total thymocytes obtained from infected mice were assayed at 0.01, 0.1, 1, 10 and 100 nM S1P. Our data show two
peaks of migration, in 0.1 and 10 nM S1P. Phenotype characterization of migrating cells by FACS analysis showed that the higher migratory response
of CD42CD82 thymocyte subset occurs towards 0.1 nM S1P (panel B), whereas CD4+CD8+ thymocyte subset migrates mainly through 10 nM stimuli
of the agonist (C). Data show mean 6 SE in four independent experiments using three pooled thymuses. Differences between S1P and BSA groups
are significant # (p,0.05) and ### (p,0.001). The migratory responses of FACS isolated CD4+CD8+ (D) and CD42CD82 (E) T cells from uninfected
and infected mice were assessed in transwell chambers towards 0.1 nM S1P stimulus. Our data show an increased S1P-driven migration of
CD42CD82 thymocytes obtained from infected mice present as compared to non-infected controls. Data show mean 6 SE in three independent
experiments using five pooled thymuses. Differences between uninfected and infected groups are significant ** (p,0.01). Differences between S1P
and BSA groups are significant ## (p,0.01). (F) Migrating CD42CD82 cells were characterized by flow cytometry analysis according to the
expression of the following phenotypic markers: CD11b (macrophages), CD11c (dendritic cells), CD45 (B cells), CD161 (NK T cells) and TCRd;
Intrathymic CD42CD82 T cell progenitors (others) were characterized by the absence in the expression of these markers. Data show means 6 SE per
103 cells characterized in two independent experiments. (G) The determination of the S1PR1-dependent migration of CD42CD82 T cells isolated from
infected mice was assessed upon treatment of the cells with the functional antagonist of S1P receptors FTY720 (102 nM) during 30 min at 37uC
previously to migration in transwell chambers towards the 0.1 nM S1P stimulus. A representative FACS profile is shown from one of three
independent experiments. The ratio of CD42CD82TCR Vb+ cells was obtained and the background staining eliminated using the isotype control
antibody. (H) We show an increase in the absolute numbers of total and TCRVb+CD42CD82 T cell migration toward the S1P stimulus. This is
prevented when the cells were previously incubated with FTY720. Data show mean 6 SE in two independent experiments using five pooled
thymuses. Differences between S1P and BSA groups are significant ## (p,0.01).
doi:10.1371/journal.pntd.0003203.g004
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to noninfected individuals. Such an increase was not seen in
patients at the indeterminate form of the chronic disease (Fig. 7A).
These results indicate the positive correlation between the
frequencies of circulating CD42CD82 T cells and cardiomyop-
athy in chronic human Chagas disease. Moreover, we showed
there is a statistically significant increase in the activation profile of
extrathymic circulating CD42CD82 T cells in chagasic patients as
compared to normal individuals by assessing the expression of
activation marker HLA-DR from peripheral blood cells (Fig. 7B).
Discussion
This study documents the effects of a well-characterized
selective agonist sphingosine 1-phosphate upon thymic atrophy
and immature T cell release during T. cruzi acute infection. In the
thymus, endothelial cells as well as thymic epithelial cells are the
major sources of extracellular S1P [40–42]. Sphingosine 1-
phosphate levels are known to be very high (0.1–1 mM) in the
blood, relative to other tissues, and to directly stimulate the
migration of mature thymocytes out of the thymus via sphingo-
sine-1-phosphate-specific chemotactic receptors [24,32]. Although
the concentration of plasma S1P is very high, it does not detectably
enter the thymic compartments due to a S1P transporter in
vascular endothelial cells that maintains high levels of S1P in the
plasma in parallel with low levels within the thymic parenchyma
[29]. SIP is also kept in low concentration in thymic tissue by
decreased sphingosine kinase and augmented S1P lyase [26,32].
Herein we demonstrated an imbalance of the S1P pathway in the
thymus during Trypanosoma cruzi acute infection in mice. Our
findings indicate a concomitant reduction in the transcriptional
levels of the S1P kinases 1/2 together with an upregulation of the
Figure 5. Treatment with FTY720 promotes thymic sequestration of CD42CD82 T cells with reduction of the corresponding
peripheral pool during T. cruzi infection. Infected mice had been pretreated with FTY720 or saline every 2 days, starting at day 6 post-infection
with T. cruzi parasites. At day 17 post-infection, thymocytes were harvested and (A) absolute cell numbers were determined by direct counting. (B)
The cytofluorometric profiles of thymocytes were obtained after staining with anti-CD4 and anti-CD8 mabs. A representative FACS profile is shown
and the ratio of each thymocyte population given as means 6 SE. (C) The absolute numbers of CD42CD82, CD4+CD8+, CD4+ and CD8+ thymocytes
were determined. CD42CD82 T cells are increased in FTY720-treated mice by 500%, when compared to infected untreated mice. (D) The
accumulation of CD42CD82TCRVb+ T cells in the SCLN during infection was significantly reduced in infected mice treated with FTY720. Data show a
means 6 SE in two independent experiments using five pooled thymuses. (E) Representative FACS profile of cells from SCLN after staining with anti-
CD4 and anti-CD8 mabs (upper panel). Histograms represent TCRVb expression in both immature CD42CD82 T cells (TCR negative/low) and CD8+
mature thymocytes (TCR high). The background staining was defined using the isotype control antibody. Differences between uninfected and
infected groups are significant * (p,0.05), ** (p,0.01) and *** (p,0.001). Differences between FTY720-treated and untreated infected groups are
significant # (p,0.05) and ## (p,0.01).
doi:10.1371/journal.pntd.0003203.g005
Early Release of Double-Negative Thymocytes in Chagas Disease
PLOS Neglected Tropical Diseases | www.plosntds.org 10 October 2014 | Volume 8 | Issue 10 | e3203
lyase gene. The transcriptional levels of the metabolic genes
involved in the S1P pathway indicate a catabolic pattern. In fact,
the reduced intrathymic levels of S1P kinase activity point out
reduced a level of S1P along with infection.
Sphingosine-1-phosphate, via signaling through the S1PR1
receptor, has been previously shown to be a chemotactic factor for
a variety of cell types including T lymphocytes [24,43,44]. The
S1P receptors are expressed on diverse cell types and tissues,
suggesting that the signaling pathway mediated by this receptor
may be involved in multiple physiological processes [45,46].
Several studies have demonstrated that the S1PR1 expression on
T cells has a crucial function in the process by which differentiated
thymocytes exit from the thymus and enter the blood. Under
physiological conditions, the S1P1 receptor level is up-regulated in
mature single positive thymocytes relative to immature double-
positive thymocytes [24]. During T cell development, TCR
signaling induces the expression of CD69, which downregulates
S1PR1 surface expression, preventing the premature S1P-medi-
ated thymocyte export from the thymus [25,47,48].
We found an increase in the expression of the S1PR1 and S1PR3
on CD42CD82 T cells during the acute phase of T. cruzi infection.
This increased expression of both chemotatic attractant receptors
involved in thymocyte trafficking could lead to high sensitization of
the CD42CD82 T cells to the reduced levels of S1P in the infected
thymus. In fact, these cells responded to lower levels of S1P and
migrated ex vivo. In the light of these findings, and considering that
the persistent use of agonists causes desensitization of the S1P
pathway, we took advantage of the in vivo use of prolonged
FTY720 treatment, which is known to lead to internalization and
lysosomal degradation of S1P receptors [49]. Such process allows
receptors to recycle, thus maintaining a functional receptor reserve,
which in turn results in a blockage of the thymocyte emigration to
the periphery [33,50]. Other studies have used this S1P receptor
inhibitor therapeutically in experimental murine T. cruzi infections
and have shown a reduction of protective immunity due to
sequestration of the lymphocytes in lymphoid organs, thus blocking
their re-circulation mediated by sphingosine-1-phosphate receptors
[51]. In our model, the onset of acquired immunity was not affected,
since we started administrating FTY720 on day 6 post-infection, just
before thymic atrophy got underway. Importantly, our in vivo
studies with FTY720 demonstrated the accumulation of double-
negative thymocytes, suggesting that the thymic egress of
CD42CD82 T cells during acute T. cruzi infection is rapidly
regulated by the S1P receptors.
These findings indicate that chagasic acute infection promotes
thymic alterations, which result in modulation of S1P-S1P1
receptor axes on intrathymic CD42CD82 T cells. This switch
renders undifferentiating thymocytes capable of responding to
chemotaxis mediated by S1P during thymic emigration. Indeed,
CD42CD82 peripheral T cells, have been proposed to originate
in the thymus by escaping negative selection followed by migration
in the periphery [52]. The presence of immature CD42CD82 T
cells bearing low TCR levels (DN3 and DN4) in the periphery may
have implications for the host-parasite interplay, since they could
be activated ex vivo. Previous findings revealed that unconven-
tional CD42CD82 T cells in the periphery are able of recognizing
antigens and subsequently signaling through their TCR in a
MHC-independent manner [53,54]. It has been demonstrated
that the peripheral CD42CD82 T lymphocytes can undergo
extrathymic T cell lymphopoiesis and that this process is severely
compromised in IL-152/2 and IL-2Rb2/2 mice [55]. These cells
have been shown to have pathogenetic properties in other models,
in which their frequencies are increased. Several studies provided
a direct link between CD42CD82 T cells and the development of
Figure 6. mRNA levels for TNF-a and IL-17a of CD42CD82CD3+ T cell subset in T. cruzi infected mice. (A) CD42CD82 T cells purified by
cell sorting using flow cytometry from 3 pooled thymuses from control and T. cruzi infected mice at day 14 post-infection to a purity higher than 95%
to access (B) the transcriptional levels of the pro-inflammatory cytokine TNF-a and IL-17a genes after in vitro stimulation with phorbol 12-myristate
13-acetate (PMA) and ionomycin in the presence of brefeldin A, during 3 hours at 37uC. The cytokine transcripts were assessed by qPCR and
normalized to GAPDH. Data show the means 6 SE in two independent experiments. Differences between uninfected and infected groups are
significant ** (p,0.01).
doi:10.1371/journal.pntd.0003203.g006
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human autoimmune diseases. In patients with systemic lupus
erythematous, these cells are the major producers of IL-17 and
infiltrate the kidneys [21]. CD42CD82 T cells have also been
found in the blood of myasthenia gravis patients and normaliza-
tion in the number of these cells was seen after thymectomy, in
parallel with clinical improvement and reduction in anti-acetyl-
choline receptor antibody titers [56]. While both systemic lupus
erythematous and myasthenia gravis are a primary autoimmune
disease, in Chagas disease the autoimmune manifestations are
considered to be secondary to the parasite-driven tissue damage
[57]. Around 30% of T. cruzi chronically infected individuals are
at risk of developing myocardial damage. The mechanisms
underlying heart disease are linked to several processes like
microvascular alteration, and molecular-mimicry related autoim-
mune reactions. Although different studies have demonstrated in
autoimmune disease and infection models the presence of
immature thymocytes in the periphery, the pathophisiological
consequences of this phenomenon have not yet been elucidated. It
is possible that premature released immature thymocyte could
express forbidden abTCR with self-antigen specificities and thus
induce autoimmune responses.
Importantly, we showed that the purified thymic CD42CD82
T cells from T. cruzi-infected mice expressed high contents of
TNF-a and IL-17a transcripts upon activation.
CD42CD82 T cells have been reported to play a key role in
various models of infections. These lymphocytes are the major
responding T cell subset in the lung of mice infected with F.
Tularensis bacterium, releasing large amounts of IL-17a during the
early stages of infection whereas CD4+ T cells start to produce this
cytokine later [20]. As these cytokines mediate pro-inflammatory
responses, the extrathymic CD42CD82 T cells may have a role in
the pathogenesis of Chagas diseases. Most interestingly, we found
that patients having the cardiac form of chronic human Chagas
disease bear higher levels of circulating CD42CD82 T lympho-
cytes than non-infected individuals. These data suggest that this T
cell subset might be associated with the development of the cardiac
form of the disease.
Overall, the studies in the mouse model indicate an imbalance
of the S1P metabolic pathway, leading to reduced levels of the
bioactive natural agonist S1P in the thymus during the
experimental T. cruzi acute infection. This imbalance was
associated with an increased expression of the S1PR1 and
S1PR3 receptors in CD42CD82 T cells. Moreover, migration of
CD42CD82 T cells from infected thymus is influenced by S1P
both ex vivo and in vivo, pointing out an important role of S1P
receptors in regulating the abnormal release of immature
thymocytes to the periphery in acute Chagas disease. It is
possible that CD42CD82 T cells have a role in modulating
adaptive immune responses in T. cruzi infections as we found
they can induce activation of pro-inflammatory cytokine genes
when they themselves are activated.
Lastly, our results indicate a connection between the
changes in the levels of the CD42CD82 T cell subset and
the severity of myocardial lesions in human Chagas disease.
These observations identify a potential clinical marker of
disease progression.
Supporting Information
Figure S1 Thymic atrophy in acute phase of T. cruzi
infection. Representative flow cytometric profiles showing
CD4+, CD4+CD8+ and CD42CD82 thymic subpopulations
during the course of infection. Of note, DP thymocytes virtually
disappeared after 21 days post-infection.
(TIF)
Figure S2 Intrathymic injection of FITC randomly
stained the thymocyte subpolulations. FACS plots showing
a high proportion of thymocytes randomly stained by the
intrathymic inoculation of FITC in both uninfected (upper panels)
and infected mice (bottom panels).
(TIF)
Figure S3 Trypanosoma cruzi acute infection promotes
the release of FITC+ thymocyte CD42CD82CD442
CD252 cells to the periphery. Mice were intrathymically
injected with FITC solution or PBS only as a control. After 24 h,
spleens were harvested and cells stained with anti-CD4, anti-CD8,
anti-CD44 and anti-CD25 for the identification of the specific
subsets of CD42CD82 recent thymic emigrants (RTEs) by flow
cytometry. (A) Upper panels represent the percentage of total
Figure 7. Increased numbers of CD42CD82 T lymphocytes in
peripheral blood from chronic chagasic patients. Peripheral
whole blood from non-infected individuals, patients at the indetermi-
nate and cardiac forms of Chagas disease were analysed by four-color
flow cytometry for expression of CD3, CD4, CD8 and HLA-DR markers.
(A) The frequency of circulating human CD42CD82 T cells was
measured in peripheral blood from non-infected individuals (n = 10),
patients at the indeterminate (n = 12) and cardiac forms of Chagas
disease (n = 11). Cells were analyzed by three-color flow cytometry for
expression of CD3, CD4 and CD8. The percentages of CD42CD82CD3+ T
lymphocytes are indicated for each histogram. (B) The activation profile
of CD42CD82CD3+ T are shown by assessing the expression of HLA-DR.
The significant differences between the groups were considered with#
(p,0.05), * (p,0.05) and *** (p,0.001).
doi:10.1371/journal.pntd.0003203.g007
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FITC+ CD42CD82 T cells in spleen during T. cruzi acute
infection and uninfected mice, while bottom panels represent the
percentage of DN1 (CD44+CD252), DN2 (CD44+CD25+), DN3
(CD442CD25+) and DN4 (CD442CD252) among
FITC+CD42CD82 migrating cells (B) Graphs represent the
absolute number of splenic FITC+ DN thymocyte subsets
regarding the expression of CD44 and CD25 markers during T.
cruzi acute infection and uninfected mice. Results are expressed as
mean 6 SE (n= 3–5 mice per group). Differences between
uninfected and infected mice are significant * (p,0.05), ** (p,
0.01), *** (p,0.001).
(TIF)
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